Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.07 | 0.2 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |